DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 076994
NDA 076994 describes HALOBETASOL PROPIONATE, which is a drug marketed by Fougera Pharms, G And W Labs, Perrigo Israel, Taro, G And W Labs Inc, and Teligent Pharma Inc, and is included in ten NDAs. It is available from six suppliers. Additional details are available on the HALOBETASOL PROPIONATE profile page.
The generic ingredient in HALOBETASOL PROPIONATE is halobetasol propionate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
The generic ingredient in HALOBETASOL PROPIONATE is halobetasol propionate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the halobetasol propionate profile page.
Summary for 076994
| Tradename: | HALOBETASOL PROPIONATE |
| Applicant: | Taro |
| Ingredient: | halobetasol propionate |
| Patents: | 0 |
| Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal) |
Pharmacology for NDA: 076994
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Suppliers and Packaging for NDA: 076994
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| HALOBETASOL PROPIONATE | halobetasol propionate | OINTMENT;TOPICAL | 076994 | ANDA | Taro Pharmaceuticals U.S.A., Inc. | 51672-1322 | N | 51672-1322-3 |
| HALOBETASOL PROPIONATE | halobetasol propionate | OINTMENT;TOPICAL | 076994 | ANDA | Taro Pharmaceuticals U.S.A., Inc. | 51672-1322 | N | 51672-1322-1 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.05% | ||||
| Approval Date: | Dec 16, 2004 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
